How We Treat Blood Cancers

At NewYork-Presbyterian, our multidisciplinary blood cancer team creates a personalized treatment plan for you. Your team meets with you and your caregivers to ensure everyone understands all treatment options so you can make an informed decision about what’s best for you. Our ultimate goal is to find a cure for your disease. Your therapy may include:


Our doctors may prescribe chemotherapy, the most common treatment for blood cancers. You may receive one drug or several in combination, depending on your cancer type, stage, and biology. While some of these medications are taken by mouth, many others are given intravenously (by vein). We give intravenous chemotherapies as in outpatient in our warm, supportive infusion centers, where our experience team can monitor any side effects and address your comfort. You may also receive chemotherapy as in inpatient in specially designated nursing units where the staff is attuned to your needs.

Targeted Therapies

Some newer targeted anticancer drugs zero in on the molecular signals driving cancer growth. These treatments are designed to take aim directly at cancer cells while sparing healthy cells, often resulting in fewer side effects than conventional chemotherapy.

For blood cancers, many new targeted therapies have been developed in the last several years that treat these cancers more precisely than conventional anticancer drugs. Your doctor will let you know if a targeted therapy is right for you.

Bone Marrow Transplantation

NewYork-Presbyterian offers bone marrow and stem cell transplantation for people with leukemia, lymphoma, multiple myeloma, myelofibrosis, and myelodysplastic syndromes (MDS). Bone marrow and stem cell transplantation at NewYork-Presbyterian includes screening for appropriate and innovative clinical trials that study novel treatment approaches.

Bone marrow transplantation has evolved into the standard of care for many people with hematologic cancers and other blood disorders. We perform more than 200 bone marrow transplants a year and pride ourselves on exceptional transplant outcomes that improve our patients' quality of life.

If your doctor recommends a transplant, you'll receive it from a team with an established track record in a hospital where all your medical needs can be addressed. We have advanced transplant units offering individual monitoring and special airflow systems for patients with weakened immune systems. We also have special expertise in transplants from mismatched donors and offer approaches that reduce the risk of transplant-related complications.

Radiation Therapy

Radiation therapy is less commonly used to treat blood cancers but is sometimes used to treat symptoms or to prepare a patient for bone marrow transplantation. Our radiation therapy units feature the latest highly precise radiation delivery equipment. Your doctor will let you know if radiation therapy is part of your treatment plan.

Clinical Trials

NewYork-Presbyterian is home to a vigorous translational research program, where basic science researchers collaborate with clinical researchers to expedite the translation of innovative laboratory findings to the clinic, where patients will benefit from cutting-edge research. The successful treatment of many blood cancers relies on clinical trials, and NewYork-Presbyterian has a robust portfolio of these studies. All of the treatments used today to care for people with blood cancers were first evaluated in these pivotal studies. Your doctor will let you know if you can participate in a clinical trial.




Columbia New Patient Access Number: